Sanderling

Results: 86



#Item
51JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte -- Treatment being developed would use encapsulation to protect new insulin-producing cells derived from a stem cell precursor -New York

JDRF and California Institute for Regenerative Medicine Increase Funding of ViaCyte -- Treatment being developed would use encapsulation to protect new insulin-producing cells derived from a stem cell precursor -New York

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-02-21 00:17:52
52Cell biology / Developmental biology / Emerging technologies / Stem cell / Embryonic stem cell / Geron Corporation / Cell therapy / Insulin / Regenerative medicine / Biology / Stem cells / Biotechnology

ViaCyte’s Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012 San Diego, California, January 31, 2013 — ViaCyte, Inc., a leading regenerative medicine company focused on developin

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-02-21 00:18:38
53Microsoft Word[removed]Chimerix IPO Pricing Release FINAL

Microsoft Word[removed]Chimerix IPO Pricing Release FINAL

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-04-15 22:10:29
54FOR IMMEDIATE RELEASE Infraredx and Philips Announce Collaboration to Develop a New Standard of Catheterization Lab Integration for True Vessel Characterization Companies to Produce New Offering that Combines Market Lead

FOR IMMEDIATE RELEASE Infraredx and Philips Announce Collaboration to Develop a New Standard of Catheterization Lab Integration for True Vessel Characterization Companies to Produce New Offering that Combines Market Lead

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2012-10-17 13:32:51
55TM  MAKING LIFE BETTER, EVERY DAY TheraVida Announces Positive Top-Line Phase 2 Results for Tolenix™ (THVD-201) in Patients with Overactive Bladder and Urge Urinary Incontinence

TM MAKING LIFE BETTER, EVERY DAY TheraVida Announces Positive Top-Line Phase 2 Results for Tolenix™ (THVD-201) in Patients with Overactive Bladder and Urge Urinary Incontinence

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-01-17 23:37:12
56Infraredx Announces Nipro Corporation’s Plans for Commercial Manufacturing of TVC Imaging System in Japan -- Japan-based Production Capability Supports Infraredx’s Planned Commercial Expansion into Broader Asia Pacif

Infraredx Announces Nipro Corporation’s Plans for Commercial Manufacturing of TVC Imaging System in Japan -- Japan-based Production Capability Supports Infraredx’s Planned Commercial Expansion into Broader Asia Pacif

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2014-01-18 22:23:05
57FOR IMMEDIATE RELEASE Philips Healthcare and Infraredx Introduce Solution to Enable Seamless Integration of TVC Imaging System with Philips’ Allura Xper Systems New software offering facilitates combined use of X-rays,

FOR IMMEDIATE RELEASE Philips Healthcare and Infraredx Introduce Solution to Enable Seamless Integration of TVC Imaging System with Philips’ Allura Xper Systems New software offering facilitates combined use of X-rays,

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-03-11 18:54:46
58Microsoft Word[removed]Chimerix BMT Tandem 2013 Data Release - FINAL

Microsoft Word[removed]Chimerix BMT Tandem 2013 Data Release - FINAL

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-02-21 00:17:10
59ASTUTE MEDICAL COMPLETES $13 MILLION

ASTUTE MEDICAL COMPLETES $13 MILLION

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-12-20 21:22:06
60Microsoft Word[removed]Ernie Mario BOD release - FINAL

Microsoft Word[removed]Ernie Mario BOD release - FINAL

Add to Reading List

Source URL: www.sanderling.com

Language: English - Date: 2013-02-21 00:17:12